BiopharmaTrend.com

Insitro

Insitro

Private company
INSITRO

A constellation of technologies now allows us to construct, perturb, and observe biological model systems in the laboratory, allowing the generation of biomolecular data at unprecedented breadth and scale. At the same time, the tools of data science and machine learning are now solving problems previously thought to be decades away from solution.

We aim to combine these technologies to develop a new approach to drug development that might help us cure more people, sooner, and at a much lower cost.


Founded
2018
Status
Private company
Geography
United States of America based
Funding
$243 M
Research papers
5

Products

No products posted yet

Services

No services posted yet


This data is part of our proprietary analytics report:

This service is currently only supported on the desktop screens, please, use this service from your desktop or laptop for correct visualization and functionality

Go to home page